Cannabics Pharmaceuticals appoints CFO
Perspectivas América Latina 2023 Emerging Trends & Growth
Insight Weekly: SVB fallout limited; US rents up; renewable natural gas investments flow in
A Cloud Migration Plan for Corporations featuring Snowflake®
Investor Activism Campaigns Hit Record High in 2022
Cannabics Pharmaceuticals Inc. appointed Uri Ben-Or as CFO following the resignation of Dov Weinberg.
Ben-Or has over two decades of experience in corporate finance, accounting, M&A transactions, IPOs and operations, having served as an auditor at PricewaterhouseCoopers.
